ARM and CARM Announce Strategic Partnership to Advance Regulatory Harmonization for Cell and Gene Therapies in the US and Korea
June 05, 2024
June 05, 2024
SAN DIEGO, California, June 5 -- The Alliance for Regenerative Medicine issued the following news release:
The Alliance for Regenerative Medicine (ARM) and the Council for Advanced Regenerative Medicine (CARM) in Korea signed a Memorandum of Understanding (MOU) to expand overseas exchange and harmonize regulations for cell and gene therapies (CGTs).
This landmark partnership seeks to bolster efforts in aligning regulatory frameworks between the United States and Korea a . . .
The Alliance for Regenerative Medicine (ARM) and the Council for Advanced Regenerative Medicine (CARM) in Korea signed a Memorandum of Understanding (MOU) to expand overseas exchange and harmonize regulations for cell and gene therapies (CGTs).
This landmark partnership seeks to bolster efforts in aligning regulatory frameworks between the United States and Korea a . . .